|
|
Office Locations:
|
31 Pond View Lane
Concord, MA 01742
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
GreyBird Ventures is an early stage venture capital firm that invests in companies developing products for precision medicine. The technologies in focus have the characteristics of high specificity and the capability to dramatically improve the choice of optimum therapy and reduce cost. Companies will have a well-protected IP position and management with deep domain knowledge and a sense of creative thrift. Founded by Michael Devlin and Tom Miller, the firm is in the early stages of fund-raising but already has investments in prototypical portfolio companies. GreyBird has recruited a team of eight operating advisors located in North America, Europe, and Asia with deep domain expertise and operating experience.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
